MENU
BIB
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

ProShares Ultra Nasdaq Biotechnology (BIB) Ownership - Who owns ProShares Ultra Nasdaq Biotechnology?

The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®... Show more

Category: #Trading

Profile

Category
Trading--Leveraged Equity
Address
ProShares Trust7501 Wisconsin Avenue,Suite 1000Bethesda
Phone
N/A
Web
www.proshares.com

Details

Group
Alternative Funds
Category
Trading
Net Assets
87916056.00
Fund Existence
over 15 years
Turnover
28.00
Capitalization
N/A
Yield
1.05
Total Expense Ratio
0.95
Investment Style
N/A
Risk (Beta)
1.46

Fundamentals

BIB
Net Assets
87.9M
Yield
1.05
Fund Existence
over 15 years
Total Expense Ratio
0.95
Turnover
28.00
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
1.46
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
1.19
Assets in Top Ten Holdings
54.7M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
87.9M
Fund Type
ETF
Index Fund
Yes
Management Fee
0.75
Modified Duration
N/A
No Load Fund
Yes
Number of Long Holdings
254.00
Number of Net Holdings
255.00
Number of Short Holdings
1.00
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
38.08%
Gain YTD
67.069
View a ticker or compare two or three
BIB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Fundamentals
Details
Category
Trading--Leveraged Equity
Address
ProShares Trust7501 Wisconsin Avenue,Suite 1000Bethesda
Phone
N/A
Web
www.proshares.com